---
companies:
- category: unknown
  confidence: medium
  context: Welcome everyone to the AI and Business Podcast. I'm Matthew Damello, Editorial
    Director here at
  name: Business Podcast
  position: 31
- category: unknown
  confidence: medium
  context: come everyone to the AI and Business Podcast. I'm Matthew Damello, Editorial
    Director here at Emerge AI Research. T
  name: Matthew Damello
  position: 53
- category: unknown
  confidence: medium
  context: the AI and Business Podcast. I'm Matthew Damello, Editorial Director here
    at Emerge AI Research. Today's guest is Dami
  name: Editorial Director
  position: 70
- category: unknown
  confidence: medium
  context: . I'm Matthew Damello, Editorial Director here at Emerge AI Research. Today's
    guest is Damien Nero, Head of Data Scien
  name: Emerge AI Research
  position: 97
- category: unknown
  confidence: medium
  context: ctor here at Emerge AI Research. Today's guest is Damien Nero, Head of
    Data Science in US Medical at Takeda Pha
  name: Damien Nero
  position: 134
- category: unknown
  confidence: medium
  context: I Research. Today's guest is Damien Nero, Head of Data Science in US Medical
    at Takeda Pharmaceuticals. With ove
  name: Data Science
  position: 155
- category: unknown
  confidence: medium
  context: y's guest is Damien Nero, Head of Data Science in US Medical at Takeda
    Pharmaceuticals. With over 15 years of
  name: US Medical
  position: 171
- category: unknown
  confidence: medium
  context: amien Nero, Head of Data Science in US Medical at Takeda Pharmaceuticals.
    With over 15 years of experience applying AI, ma
  name: Takeda Pharmaceuticals
  position: 185
- category: unknown
  confidence: medium
  context: ', running to catch up to maybe what''s the latest. But I know we can talk
    about what we''ve seen since the'
  name: But I
  position: 1649
- category: unknown
  confidence: medium
  context: eople aren't good at writing up things like this. So I have to take time
    to think through it. AI can dra
  name: So I
  position: 3636
- category: unknown
  confidence: medium
  context: sort of a fill and with an autocorrect built in. So AI, I think, is really
    effective there. So that's wh
  name: So AI
  position: 4449
- category: unknown
  confidence: medium
  context: ansformative. We adapted by having a longer view. And I think that that's
    really one of the strengths and
  name: And I
  position: 7328
- category: unknown
  confidence: medium
  context: wo things that may not exist in the future. What? The US military for the
    last 70, 80 years or so has poli
  name: The US
  position: 8283
- category: unknown
  confidence: medium
  context: ing. Can any of you want to walk closer together? South America is looking
    for partners as well. China is taking
  name: South America
  position: 8934
- category: unknown
  confidence: medium
  context: point. Not only that, but then you have even the British Labor Party saying,
    hey, whatever the United States is doing
  name: British Labor Party
  position: 13739
- category: unknown
  confidence: medium
  context: the British Labor Party saying, hey, whatever the United States is doing
    is the United States, but overall we can
  name: United States
  position: 13785
- category: unknown
  confidence: medium
  context: t overall we can't support globalization anymore. The British worker did
    not win in globalization. Whether or n
  name: The British
  position: 13882
- category: tech
  confidence: high
  context: akeaways for pharmaceutical executives looking to scale AI in clinical
    trials and drug development. We'll su
  name: Scale Ai
  position: 27143
- category: unknown
  confidence: medium
  context: agement and life sciences sponsored by Arquestro. Join Arquestro in downtown
    Manhattan for an exclusive in-person
  name: Join Arquestro
  position: 27921
- category: unknown
  confidence: medium
  context: stry pioneers, including procurement leaders from Crown Holdings, JLL Koch,
    and
  name: Crown Holdings
  position: 28317
- category: unknown
  confidence: medium
  context: ncluding procurement leaders from Crown Holdings, JLL Koch, and
  name: JLL Koch
  position: 28333
- category: media/research
  confidence: high
  context: The host, Matthew Damello, is the Editorial Director here.
  name: Emerge AI Research
  source: llm_enhanced
- category: pharmaceuticals/tech
  confidence: high
  context: The guest, Damien Nero, is the Head of Data Science in US Medical at this
    company. The company's views are explicitly distanced from the podcast's content.
  name: Takeda Pharmaceuticals
  source: llm_enhanced
- category: sponsor/tech (implied)
  confidence: high
  context: The special series on supply chain challenges in life sciences is sponsored
    by this company.
  name: Arquestro
  source: llm_enhanced
- category: pharmaceuticals/tech
  confidence: high
  context: Mentioned as a peer company building 360-degree dashboards in the same
    space.
  name: Sanofi
  source: llm_enhanced
- category: technology/engineering
  confidence: high
  context: Mentioned alongside Sanofi as a company building 360-degree dashboards.
  name: Bosch
  source: llm_enhanced
- category: government/research
  confidence: high
  context: Mentioned in the context of funding cuts for research.
  name: NIH
  source: llm_enhanced
- category: Organization/Education
  confidence: high
  context: Mentioned as a 'brain trust' in pharma and across everything, currently
    facing conflict with the administration, highlighting its role in academia and
    research.
  name: Harvard
  source: llm_enhanced
- category: Tech/Consulting/Partner
  confidence: high
  context: Partnering with Arquestro to host an exclusive in-person advisory council.
  name: InFore
  source: llm_enhanced
- category: Pharmaceutical/Tech
  confidence: high
  context: The current employer of the guest (Damien), indicating its role in the
    pharmaceutical industry where AI is being discussed.
  name: Takeda
  source: llm_enhanced
date: 2025-06-05 07:00:00 +0000
duration: 29
has_transcript: false
layout: episode
llm_enhanced: true
original_url: https://traffic.libsyn.com/secure/techemergence/Business_-_6.5.25_-_Damion_Nero.mp3?dest-id=151434
processing_date: 2025-10-05 12:15:26 +0000
quotes:
- length: 256
  relevance_score: 5
  text: You have to look into parts of the world, Africa, South America, India, where
    populations are actually growing and where you're going to have a market of young
    productive workers who are going to build up enough resources to be able to pay
    for our products
  topics:
  - market
- length: 202
  relevance_score: 3
  text: Just really taking the thousand-foot view here, where are you seeing AI-driven
    efficiencies currently making the biggest impact in the drug development process,
    especially when it comes to supply chains
  topics: []
- length: 79
  relevance_score: 3
  text: So you have to understand the farmer has been through this type of thing before
  topics: []
- length: 123
  relevance_score: 3
  text: With that being the case, you have to move around in these new supply routes
    because it's going to become far more regional
  topics: []
- length: 147
  relevance_score: 3
  text: Whatever is happening in terms of policy and globalization, you're going to
    see the biggest parts of that happen probably within the next two years
  topics: []
- impact_reason: A bold, high-level prediction about the macro-economic trend overriding
    short-term policy fluctuations.
  relevance_score: 10
  source: llm_enhanced
  text: What comes after is really sort of the new world order that's established.
    And what that's looking like if you look at the larger trend is de-globalization.
  topic: Industry Trends/Geopolitics
- impact_reason: 'The direct strategic implication of de-globalization: mandatory
    regionalization and localization of sourcing and manufacturing.'
  relevance_score: 10
  source: llm_enhanced
  text: Global supply is not going to be an option. So what that means is we're going
    to have to resource locally. We're going to have to pull things together at a
    level that we haven't done before.
  topic: Business/Strategy
- impact_reason: 'A fundamental shift in R&D strategy: moving away from mass-market
    ''blockbusters'' toward targeted therapies due to demographic and market changes.'
  relevance_score: 10
  source: llm_enhanced
  text: We are going to have to change our pipeline so that it is not geared towards
    blockbusters anymore, but rather drugs that are designed for specific populations
    worldwide.
  topic: Business/R&D Strategy
- impact_reason: A stark, geopolitical warning about the end of the Pax Americana
    framework that underpinned decades of globalized trade efficiency.
  relevance_score: 10
  source: llm_enhanced
  text: We rely on two things that may not exist in the future. What? The US military
    for the last 70, 80 years or so has policed the world's oceans and allowed for
    free transport and trade that's going away.
  topic: Industry Trends/Geopolitics
- impact_reason: Raises a crucial, actionable concern for data scientists and AI practitioners
    regarding model robustness when trained on anomalous historical data.
  relevance_score: 10
  source: llm_enhanced
  text: if we're training this data on a very volatile, irregular period of supply
    chain history, how is that going to fare for us in the long term if there's even
    a glimmer of returning to normal?
  topic: Technology/Data Science/AI Ethics
- impact_reason: Identifies AI's localization capability as a key strategic advantage,
    particularly in highly regulated or fragmented environments (like precision medicine).
  relevance_score: 10
  source: llm_enhanced
  text: precision medicine as being one of the silver linings of the situation that
    we're seeing of a huge use case for artificial intelligence is localization capabilities
    and being able to really fine-tune with nuance and specify approaches across...
    right down to localities, especially when it comes to compliance and individual
    jurisdictions.
  topic: Technology/AI Applications
- impact_reason: Articulates the ultimate, aspirational goal of personalized medicine
    enabled by advanced data and AI.
  relevance_score: 10
  source: llm_enhanced
  text: the end goal of all of this and the hope in all of this is that we can eventually
    just start developing drugs and just work on you. One point that that drug will
    work with a 95% accuracy and there won't be any issues with side effects or anything
    else because it is tailored specifically to your genome, to your physiology...
  topic: Technology/Future of Medicine
- impact_reason: A crucial reality check for the industry, indicating that transformative
    AI adoption in complex areas like drug supply chains is still nascent, despite
    hype.
  relevance_score: 9
  source: llm_enhanced
  text: Well in terms of supply chains, I don't think the impact is really quite there
    yet.
  topic: Technology/Supply Chain
- impact_reason: A strong statement on the current capability of generative AI to
    outperform human experts in specific, routine content creation tasks (e.g., employee
    reviews, routine reports).
  relevance_score: 9
  source: llm_enhanced
  text: AI can draft this far better than even some of our best medical writers in
    some cases, even for routine things.
  topic: Technology/AI Capability
- impact_reason: 'A critical distinction: current AI impact is often incremental (making
    existing bad processes slightly faster) rather than fundamentally transformative.'
  relevance_score: 9
  source: llm_enhanced
  text: even the benefits still tend to be for reactive workflows. As you mentioned,
    everybody still doing the paperwork, the paperwork's still there.
  topic: Business/Strategy
- impact_reason: Identifies the erosion of global security infrastructure as a fundamental
    threat to established global supply chains.
  relevance_score: 9
  source: llm_enhanced
  text: The US military for the last 70, 80 years or so has policed the world's oceans
    and allowed for free transport and trade that's going away. That is on an inexorable
    path for the last 10 years of being just wound down.
  topic: Industry Trends/Supply Chain Risk
- impact_reason: Directly links the geopolitical/supply chain shift to the necessity
    of accelerating precision medicine development.
  relevance_score: 9
  source: llm_enhanced
  text: I had in mind the push towards precision medicine is going to have to accelerate.
    And this is where the AI piece comes in.
  topic: Technology/Precision Medicine
- impact_reason: A stark demographic warning about the shrinking, aging, and potentially
    less affluent Western consumer base for high-cost drugs.
  relevance_score: 9
  source: llm_enhanced
  text: The Western population is faltering. With the antiviration push combined with
    the low birth rates, you are going to have a situation within the next 10 to 20
    years where you have an extremely old population that is going to be running out
    of money.
  topic: Industry Trends/Demographics
- impact_reason: Identifies emerging markets with growing, younger populations as
    the future centers of pharmaceutical profitability.
  relevance_score: 9
  source: llm_enhanced
  text: You have to look into parts of the world, Africa, South America, India, where
    populations are actually growing and where you're going to have a market of young
    productive workers who are going to build up enough resources to be able to pay
    for our products.
  topic: Business/Market Strategy
- impact_reason: A major critique of current data sourcing practices in drug development,
    highlighting inherent bias and market limitation.
  relevance_score: 9
  source: llm_enhanced
  text: we, to this day, source data from the West as if the West is the only population
    that it is and we find drugs that will work on a certain portion of population
    and we have no clue if they work on the rest.
  topic: Technology/Data Sourcing
- impact_reason: 'A powerful statement on strategic planning: focus on enduring global
    shifts (like de-globalization) over short-term political cycles.'
  relevance_score: 9
  source: llm_enhanced
  text: We're more looking to the long term and really what's happening globally in
    terms of the changes that's happening that the current administration will not
    last forever regardless of how things are moving forward.
  topic: Business/Strategy
- impact_reason: Highlights a critical failure in global data sourcing, especially
    in pharma/AI, emphasizing the need to diversify data beyond Western populations
    for effective product design.
  relevance_score: 9
  source: llm_enhanced
  text: we're going to have to play more in these markets than we ever had before
    because we, to this day, source data from the West as if the West is the only
    population that it is and we find drugs that will work on a certain portion of
    population and we have no clue if they work on the rest.
  topic: Technology/Data Sourcing/Global Strategy
- impact_reason: A strong strategic warning against market myopia, urging businesses
    to look beyond established, wealthy markets to the majority of the global population.
  relevance_score: 9
  source: llm_enhanced
  text: You can't design your entire market around 1 billion people that may or may
    not be wealthy today or not to be wealthy tomorrow. You've got to focus on the
    other over 6 billion people.
  topic: Business/Market Strategy
- impact_reason: A definitive, high-impact statement summarizing the irreversible
    nature of the current geopolitical and economic shifts.
  relevance_score: 9
  source: llm_enhanced
  text: The old world is not coming back.
  topic: Industry Trends
- impact_reason: Directly links regulatory/geopolitical volatility to the critical
    need for reassessing data governance frameworks.
  relevance_score: 9
  source: llm_enhanced
  text: if the rules are changing, the regulations are changing, the global situation
    is changing... you're going to be worried about what impact that's going to have
    on your data governance going forward.
  topic: Technology/Data Governance
- impact_reason: A dramatic assessment of the current data quality and accessibility
    crisis, particularly in health/science sectors.
  relevance_score: 9
  source: llm_enhanced
  text: But we are facing a real dark age in terms of data that is going to be meaningful.
  topic: Technology/Data Quality
- impact_reason: Actionable insight into the shift from mass-market drug development
    to hyper-localized, precision design.
  relevance_score: 9
  source: llm_enhanced
  text: I'm really trying to gather more intelligence locally to design drugs better
    for some subpopulation, smaller populations.
  topic: Startups/R&D Strategy
- impact_reason: 'Defines a new, decentralized success metric for pharma/biotech:
    portfolio diversity over single blockbuster reliance.'
  relevance_score: 9
  source: llm_enhanced
  text: getting more drugs on the market so that the investment that goes in is returned
    not by having one blockbuster, but instead having maybe 40 or 50 drugs that are
    performing really well and having multiple variations of each of those drugs that
    work on various different populations eventually down to the individual.
  topic: Business/Investment Strategy
- impact_reason: A crucial reminder of the ethical weight and required methodical
    pace in life-critical industries (like health tech) compared to consumer tech.
  relevance_score: 9
  source: llm_enhanced
  text: unlike if you're putting out some widget or some plastic toy or a burger or
    whatever, our products are keeping people alive and potentially taking their lives.
    And we have to take that seriously in everything that we do.
  topic: Business/Ethics/Pace of Innovation
- impact_reason: Sets a critical inflection point (end of 2026) for geopolitical stabilization,
    linking it directly to economic survival.
  relevance_score: 9
  source: llm_enhanced
  text: At the end of '26, the world order will have shifted about as much as it's
    going to in the immediate because it's going to have to settle down. Otherwise,
    we'll have another great depression.
  topic: Forecasting/Geopolitics
- impact_reason: Defines the two extreme potential outcomes of current global instability,
    forcing listeners to consider high-stakes scenarios.
  relevance_score: 9
  source: llm_enhanced
  text: One of those two things is going to happen. Either we're going to have a great
    depression, in which case all of this stops for a go while, or we're going to
    have a functional transformation that everybody can work through.
  topic: Risk Assessment/Business Continuity
- impact_reason: Identifies precision medicine, powered by AI, as the key strategic
    direction for future drug development.
  relevance_score: 9
  source: llm_enhanced
  text: Localized precision medicine is largely the way of the future, with AI playing
    a crucial role in tailoring drug development to specific patient populations,
    improving both outcomes and efficiency.
  topic: AI Application/Future Trends
- impact_reason: Highlights the significant capital expenditure and time required
    for physical infrastructure upgrades necessary to fully realize AI benefits in
    manufacturing and logistics.
  relevance_score: 8
  source: llm_enhanced
  text: a lot of that is going to involve really us retooling a lot of our manufacturing
    capabilities, warehousing, things like that, which is in progress, but those are
    going to take a while.
  topic: Business/Technology
- impact_reason: 'Pinpoints the immediate, tangible ROI of current AI applications:
    administrative time savings, especially in documentation and communication tasks.'
  relevance_score: 8
  source: llm_enhanced
  text: AI is definitely giving back hours to personnel that don't have to spend the
    amount of time to use, have to spend drafting things, especially since a lot of
    people aren't good at writing up things like this.
  topic: Technology/Productivity
- impact_reason: Identifies regulatory compliance and form-filling as a prime, low-hanging
    fruit for intelligent automation, requiring precision over creativity.
  relevance_score: 8
  source: llm_enhanced
  text: AI, I think, is really effective there [in regulatory submissions]... routine
    filling in the same forms over and over again. Something is very easy to automate,
    but you need sort of one intelligent automation and just sort of a fill and with
    an autocorrect built in.
  topic: Technology/Automation
- impact_reason: 'A core strategic lesson for all businesses: longevity comes from
    anticipating systemic shifts rather than reacting to daily noise.'
  relevance_score: 8
  source: llm_enhanced
  text: We adapted by having a longer view. And I think that that's really one of
    the strengths and why we have pharmaceutical companies like mine and go back to
    almost 250 years, because we ultimately understand that the world is going to
    shift and whatever direction it's going to shift in.
  topic: Business/Strategy
- impact_reason: Highlights the classic tension between short-term cost optimization
    (lean global supply) and long-term resilience (expensive redundancy).
  relevance_score: 8
  source: llm_enhanced
  text: This is something that leadership is reluctant to do because it's expensive
    to set up in the outset [creating redundancies].
  topic: Business/Leadership
- impact_reason: Emphasizes IP protection and partner reliability as primary drivers
    for shortening supply lines, overriding pure cost considerations.
  relevance_score: 8
  source: llm_enhanced
  text: We can't afford to have our IP being leaked out that way. We can't afford
    to have unreliable partners. So we'll have to have a system where if we find that's
    happening, we can immediately pull out.
  topic: Business/Risk Management
- impact_reason: 'Quantifies the scale of the necessary pivot: focusing R&D and data
    collection on the majority of the global population outside traditional Western
    markets.'
  relevance_score: 8
  source: llm_enhanced
  text: You've got to focus on the other over 6 billion people. Half of them, they'll
    be left with a population decline, but whoever's left in the outset of that and
    make drugs specifically work better for them.
  topic: Business/Market Strategy
- impact_reason: Directly connects improved, diverse data sourcing with the successful
    scaling of precision medicine.
  relevance_score: 8
  source: llm_enhanced
  text: And precision medicine numbers there if we start being smarter about how we
    source the data.
  topic: Technology/Precision Medicine
- impact_reason: Identifies a specific, high-level political statement as evidence
    of a fundamental shift away from established global reliance (de-globalization).
  relevance_score: 8
  source: llm_enhanced
  text: even the president of Canada saying, hey, we can't rely on the US anymore,
    that is a real turning point.
  topic: Industry Trends/Geopolitics
- impact_reason: Connects socio-economic outcomes of globalization to political instability,
    signaling a long-term trend against the previous global trade structure.
  relevance_score: 8
  source: llm_enhanced
  text: The British worker did not win in globalization. Whether or not that's true,
    you don't have political parties who are defending that world order winning elections
    anymore.
  topic: Business/Industry Trends
- impact_reason: Draws a clear distinction between fundamental (academic) research
    and applied (industry) research, highlighting industry's focus on commercialization.
  relevance_score: 8
  source: llm_enhanced
  text: all the research that saves people's lives is done in academia, we don't do
    it. We do research in order to push our drug pipelines in order to push our product.
  topic: Business/R&D Strategy
- impact_reason: A cautionary note on the risk of stifling paradigm-shifting innovation
    due to underfunding of foundational academic research.
  relevance_score: 8
  source: llm_enhanced
  text: the stuff that actually moves the paradigm, the stuff that actually gets us
    to the next level, that's not in academia, they've been starved for funds.
  topic: Technology/Innovation
- impact_reason: Illustrates the massive, often uncontrolled, monetization of passive
    healthcare data, relevant to data brokers and privacy concerns.
  relevance_score: 8
  source: llm_enhanced
  text: the minute they thought that they could make a dollar off of this, yeah, it
    kind of took off. And it's going from even more so. I have at least 100 active
    companies I'm working with just selling me data.
  topic: Business/Data Monetization
- impact_reason: Provides a specific, albeit cautious, timeline prediction for when
    industry-wide proactive technology adoption (post-disruption) might stabilize.
  relevance_score: 8
  source: llm_enhanced
  text: I would say probably about three years away, best case in it [proactive supply
    chain workflows]. If you're talking about an industry-wide change, I would say
    probably 2028, 2030.
  topic: Forecasting/Supply Chain Tech
- impact_reason: Connects near-term political cycles to potential dramatic shifts
    in global structure, including a cautionary note about authoritarian trends.
  relevance_score: 8
  source: llm_enhanced
  text: The backlash is already starting and there will be more election cycles by
    the end of '26 that will likely shift this dramatically unless really there is
    more of a fascistic move and we're seeing hints of that in the United States and
    the EU.
  topic: Geopolitics/Political Risk
- impact_reason: Articulates a severe, worst-case economic consequence directly linked
    to specific political trajectories.
  relevance_score: 8
  source: llm_enhanced
  text: Even if it goes that direction [fascistic move], depression, almost certainly,
    because the global economy will just collapse under the way that that and it'll
    just be militaristic rule and austerity...
  topic: Risk Assessment/Economic Collapse
- impact_reason: A concrete, immediate benefit of AI adoption in the life sciences
    sector, focusing on efficiency gains.
  relevance_score: 8
  source: llm_enhanced
  text: AI is already making a significant impact by streamlining administrative tasks
    and improving regulatory efficiency, allowing teams to focus on more strategic
    work.
  topic: AI Application/Life Sciences
- impact_reason: Clarifies the current state of AI in supply chainâ€”early wins in admin,
    but major transformation is still future-dated.
  relevance_score: 8
  source: llm_enhanced
  text: Broader, more transformative supply chain efficiencies are still in development
    with industry-wide changes expected in the coming years as AI adoption grows.
  topic: Technology Timelines/Supply Chain
- impact_reason: Suggests that early AI wins in large enterprises might manifest as
    improved employee morale and reduced burnout before showing up as massive P&L
    shifts.
  relevance_score: 7
  source: llm_enhanced
  text: a lot of that impact might be silent or at least a little bit more cultural
    than deep transformation of the entire processes that we see in supply chain.
  topic: Business/Culture
- impact_reason: Illustrates the danger of basing complex business strategy on volatile,
    poorly implemented geopolitical policies, leading to wasted effort.
  relevance_score: 7
  source: llm_enhanced
  text: The tariffs are actually not being collected. And so what's happening is that
    you have a situation where people are reacting to something that doesn't actually
    exist.
  topic: Business/Policy Risk
- impact_reason: 'Actionable advice for tech and business development: the necessary
    infrastructure/partners for global expansion already exist; engagement is the
    barrier.'
  relevance_score: 7
  source: llm_enhanced
  text: There are partners existing out there we just haven't engaged with them.
  topic: Business/Actionable Advice
- impact_reason: A concise statement confirming the end of the previous stable operating
    environment and the onset of sustained volatility.
  relevance_score: 7
  source: llm_enhanced
  text: we're probably going into a new period of time that will be a new normal.
  topic: Industry Trends
- impact_reason: A stark warning about immediate future challenges in data modeling
    and planning due to unforeseen variables.
  relevance_score: 7
  source: llm_enhanced
  text: Next year is going to be a nightmare because we're going to have to account
    for things that we didn't even contemplate before.
  topic: Business/Forecasting
- impact_reason: Offers a short-term window (two years) for peak volatility in policy
    shifts affecting global operations.
  relevance_score: 7
  source: llm_enhanced
  text: Whatever is happening in terms of policy and globalization, you're going to
    see the biggest parts of that happen probably within the next two years.
  topic: Industry Trends/Forecasting
- impact_reason: A strong prediction that legacy trade agreements are obsolete due
    to fundamental shifts in global economics.
  relevance_score: 7
  source: llm_enhanced
  text: The single trade deals, most of them are going to be worse than the ones we
    had before because a lot of them are based on notions that no longer exist.
  topic: Business/Trade Policy
- impact_reason: Insider confirmation of the aggressive monetization of healthcare
    data, relevant for startups building data platforms.
  relevance_score: 7
  source: llm_enhanced
  text: I've been on every side of that. And I can tell you that it's all being monetized,
    especially today.
  topic: Business/Data Monetization
- impact_reason: Provides a historical anecdote illustrating the extreme lack of control
    in early data handling, contrasting it with current (though still imperfect) standards.
  relevance_score: 7
  source: llm_enhanced
  text: I was put in front of a database of 50 million people with their social security
    numbers, that's how kind of uncontrolled it was in the beginning, when not there
    anymore.
  topic: Technology/Data Security History
- impact_reason: Provides a secondary timeline ('28) for when strategic transformation
    can resume after the current period of instability settles.
  relevance_score: 7
  source: llm_enhanced
  text: I think that everything will be shuffled and it will start to see once that
    settles down, then it will shift more towards the continuing transformation and
    ultimately a heavy move starting in '28 based on just what I've been seeing so
    far.
  topic: Technology Timelines/Strategy
- impact_reason: Uses the bond market reaction as evidence that financial realities
    are forcing a slowdown on aggressive policy changes (like tariffs).
  relevance_score: 7
  source: llm_enhanced
  text: I think you saw that in the whole tariff story right at the end when the bond
    market moved and I think that sent shockwaves through everybody who thought the
    tariffs were a good idea that maybe it's time to at least pump the brakes for
    how fast we're putting a lot of these changes in.
  topic: Business/Market Reaction
- impact_reason: A strong critique of political interference impacting scientific
    funding and public health data integrity.
  relevance_score: 6
  source: llm_enhanced
  text: We now have the most anti-science and anti-health, frankly, administration
    that has ever existed in this country. They are actively basically just saying
    suffer through.
  topic: Industry Trends/Policy Impact
- impact_reason: Suggests AI/tech is immediately useful for optimizing existing communication
    and distribution channels (channel strategy).
  relevance_score: 6
  source: llm_enhanced
  text: there are applications in our channel, for example, that will help us to kind
    of come up with new ways of reaching out to both healthcare providers and patients.
  topic: Technology/Marketing/Sales
source: Unknown Source
summary: '## AI in Drug Development and Supply Chain: A Strategic Pivot Amidst Global
  Volatility


  This episode of the AI and Business Podcast, featuring **Damien Nero, Head of Data
  Science in US Medical at Takeda Pharmaceuticals**, provides a high-level, yet deeply
  strategic, analysis of how AI is currently impacting drug development and the significant,
  looming transformation required in pharmaceutical supply chains due to global geopolitical
  shifts.


  ### 1. Main Narrative Arc and Key Discussion Points


  The conversation moves from the immediate, tactical applications of AI in administrative
  tasks to a broader, long-term strategic discussion about de-globalization, supply
  chain restructuring, and the necessary acceleration toward localized precision medicine.
  Nero emphasizes that while AI is currently providing significant, though often "silent,"
  efficiencies in documentation, the transformative impact on complex physical supply
  chains is still several years away, contingent upon massive infrastructure retooling
  and stabilization of the global order.


  ### 2. Major Topics and Subject Areas Covered


  *   **Current AI Impact:** Administrative tasks, regulatory submissions, and employee
  performance reviews.

  *   **Supply Chain Transformation:** The lag in AI adoption for physical logistics,
  warehousing, and distribution pattern optimization.

  *   **Geopolitical Volatility:** The impact of erratic global policy (e.g., tariffs,
  trade disputes) on pharmaceutical operations.

  *   **De-Globalization Trend:** The shift away from globalized sourcing due to the
  winding down of US-policed global trade routes and new regional trade blocs.

  *   **Precision Medicine Acceleration:** The need to pivot R&D away from blockbusters
  toward drugs tailored for specific, localized populations.

  *   **Data Governance Challenges:** Concerns over training AI models on volatile,
  irregular data sets from the recent period of global disruption.


  ### 3. Technical Concepts, Methodologies, or Frameworks Discussed


  *   **Intelligent Automation:** Specifically noted for routine regulatory form filling
  with built-in autocorrection.

  *   **Real-World Data (RWD):** Mentioned as crucial for future precision medicine
  approaches, requiring sourcing from non-traditional Western populations.

  *   **Data Monetization:** Nero notes the massive, active market for passively collected
  healthcare data, though this data is becoming "messy" due to public health shifts.


  ### 4. Business Implications and Strategic Insights


  The core strategic insight is that **pharmaceutical companies must plan for a de-globalized,
  regionalized future.** This necessitates:

  *   **Shortening Supply Lines:** Creating local sourcing and manufacturing capabilities.

  *   **Redundancy:** Leadership must overcome the initial expense of setting up multiple
  redundancies.

  *   **IP Protection:** The risk of IP leakage in less stable regions forces companies
  to have immediate exit strategies, meaning unreliable partners must be avoided.

  *   **Market Re-evaluation:** The Western market is aging and financially strained;
  future profitability hinges on developing drugs for growing populations in Africa,
  South America, and India.


  ### 5. Key Personalities and Thought Leaders Mentioned


  *   **Damien Nero (Takeda Pharmaceuticals):** The primary expert providing insights
  from the industry perspective.

  *   **Matthew Damello (Emerge AI Research):** The host guiding the discussion.

  *   **Sanofi and Bosch:** Mentioned as peers in the industry building 360-degree
  dashboards.


  ### 6. Predictions, Trends, or Future-Looking Statements


  *   **Supply Chain Proactivity Timeline:** Nero predicts that industry-wide proactive
  supply chain transformation (leveraging AI for logistics) is **three years away
  at best**, with significant industry shift expected between **2028 and 2030**.

  *   **Policy Stabilization:** The immediate, volatile policy shifts are expected
  to settle by the end of 2026, or the world risks a "great depression."

  *   **Precision Medicine Goal:** The ultimate hope is developing drugs tailored
  to an individual''s genome with 95% accuracy, eliminating broad side effects.


  ### 7. Practical Applications and Real-World Examples


  *   **Administrative Relief:** AI drafting employee reviews and routine regulatory
  documents, saving personnel 1-2 hours daily.

  *   **Supply Chain Tracking:** Future AI use in monitoring inventory and optimizing
  distribution to prevent gluts or shortages.

  *   **Market Focus Shift:** Moving away from designing drugs solely for the wealthy
  West to designing for growing global populations.


  ### 8. Controversies, Challenges, or Problems Highlighted


  *   **Data Integrity Crisis:** The current period of extreme volatility (political,
  public health) creates "a real dark age in terms of data that is going to be meaningful."
  Training models on this irregular data risks introducing significant bias.

  *   **Political Headwinds:** Active defunding of NIH and research, and political
  attacks on institutions like Harvard, threaten foundational scientific progress
  that pharmaceutical companies rely on.

  *   **Public Health Skepticism:** The rise of anti-science and anti-health sentiment
  complicates patient engagement and treatment adherence, requiring localized, nuanced
  outreach strategies.


  ### 9. Solutions, Recommendations, or Actionable Advice Provided


  *   **Adopt a Long View:** Companies must plan strategically around de-globalization
  rather than reacting only to immediate tariff chaos.

  *   **Accelerate Localized Intelligence Gathering:** Actively seek out and engage
  with partners in emerging markets to source data necessary for localized precision
  medicine development.

  *   **Measured Pace:** Due to the high-stakes nature of pharmaceuticals (life and
  death), implementation of new AI systems must be methodical, thoughtful, and slow
  to ensure patient safety and sustainability.


  ### 10. Context: Why This Conversation Matters to the Industry


  This discussion is critical because it frames AI adoption not just as a technical
  upgrade, but as a **necessary strategic response to fundamental shifts in global
  trade and demographics.** For technology'
tags:
- artificial-intelligence
- investment
- ai-infrastructure
title: Leveraging Data to Scale Drug Development Globally - with Damion Nero of Takeda
topics:
- keywords:
  - ai
  - machine learning
  - deep learning
  - neural networks
  - llm
  - large language model
  mentions: 67
  prominence: 1.0
  topic: artificial intelligence
- keywords:
  - investment
  - funding
  - valuation
  - ipo
  - acquisition
  mentions: 2
  prominence: 0.2
  topic: investment
- keywords:
  - gpu
  - tensor
  - training
  - inference
  - model deployment
  - vector database
  mentions: 1
  prominence: 0.1
  topic: ai infrastructure
---

<!-- Episode automatically generated from analysis data -->
<!-- Processing completed: 2025-10-05 12:15:26 UTC -->
